CREDIT: 2 contact hours (0.2 CEUs)
This activity was planned to meet the needs of pharmacists enrolled in the Shenandoah University Bernard J. Dunn School of Pharmacy Nontraditional Doctor of Pharmacy Pathway.
This knowledge-based online home-study activity consists of recorded lectures with PowerPoint slides and notes, readings in textbooks and journal articles, assignments, and online assessments/exams. Case studies within the lectures and assignments will enable the pharmacists to apply the information from the lectures to specific patient scenarios.
Shenandoah University Bernard J. Dunn School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Requirements for CE Credit
Pharmacists must complete the following items by the due dates specified in the online academic course that correlates to this activity to receive CPE credit:
- Review all online lectures associated with this activity.
- Complete and submit all assignments associated with this activity.
- Complete all online assessments/exams associated with this activity with an average score of 70% on all assessments. Participants will only have one opportunity to access each assessment/exam and must complete the assessment/exam within the allotted time limit.
- Complete the online CPE evaluation for this activity.
- Describe the basic principles of genetics, such as single gene inheritance, independent assortment, linkage, and genetic variation
- Explain how the genome conveys information to the rest of the body (the central dogma of molecular biology)
- Describe the general types of proteins and the impact of genetic polymorphisms on the function of these proteins
- Identify economic and policy considerations relevant to Pharmacogenomics
- Explain scientific procedures and techniques frequently performed in Pharmacogenomic research
- Apply genetic, cell, molecular, and biochemical concepts to analyze and interpret genomic data
Release Date: May 4, 2021
Credit Expiration Date: May 4, 2024